Radiotherapy of retroperitoneal soft tissue sarcoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00004307

Enrollment

Registered

2014-06-18

Start date

2012-09-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C49

Interventions

Group 1: clinical examination of retroperitoneal soft tissue sarcoma, follow up

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients treated at University Hospital Freiburg with a combined therapy including neoadjuvant radiotherapy, operation +/- intraoperative radiotherapy (IORT) and adjuvant radiotherapy due to retroperitoneal soft tissue sarcoma.

Exclusion criteria

Exclusion criteria: age < 18 years

Design outcomes

Primary

Measure	Time frame
Survival	—

Secondary

Measure	Time frame
Metasis-free survival, local recurrence-free survival, side effects	—

Countries

Germany

Contacts

Public ContactAnca-Ligia Grosu

Strahlenheilkunde des Universitätsklinikums Freiburg

anca.grosu@uniklinik-freiburg.de+49 761 270-94610

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026